Breast cancer is the second most common cancer among women in the United States, second only to skin cancer. While the breast cancer death rate has declined since its peak in 1989, many families continue to be affected by this disease each year. Furthermore, certain populations remain disproportionately burdened by breast cancer and experience greater obstacles to prevention, screening, early detection, treatment and survival, including systemic factors that are complex and go beyond the obvious connection to cancer.
The American Cancer Society collaborates with health care experts and organizations to provide the latest science and information in breast cancer prevention, screening, early detection, treatment, and survivorship.
Colorectal cancer is the second leading cause of cancer death in the United States, when data for men and women are combined, yet it can often be prevented through regular screening. The American Cancer Society is joined by experts from health care and academia to discuss issues related to colorectal cancer, from prevention through survivorship.
The global pandemic of COVID-19 continues to have a serious impact on many people, including people with cancer, their families, and caregivers. Experts from the American Cancer Society provide up-to-date information with cancer care teams, people with cancer, and caregivers in the COVID-19 related ECHO series.
A Genomic tumor board (GTB) consists of a team of multidisciplinary healthcare professionals who collaborate to review genomic tumor tests (GTT). These boards function to analyze results of GTTs to help guide potential treatment decisions using the latest research. The goal of these sessions is to work together to provide interpretation support for clinicians and engage community oncologists in a robust discussion of treatment options for the patient and evaluate actionable results.
The human papillomavirus, or HPV, can cause six types of cancers. HPV vaccination can prevent more than 90% of HPV cancers when given at the recommended ages. The American Cancer Society is collaborating with providers, health care organizations, and community leaders to provide expert advice on how to increase vaccination rates.
In the United States, lung cancer is the leading cause of cancer death in both men and women. While smoking increases the risk of several cancers and is the strongest risk factor for lung cancer, lung cancer can be diagnosed in anyone, including those who have never smoked and others with no known risk factors. The American Cancer Society is working with leading experts in lung cancer to offer cutting-edge information on lung cancer prevention, diagnosis, and treatment.
The Disparities Reducing ECHO brings recipients of three ACS and Pfizer-funded grant opportunities focused on Breath Health Equity, Addressing Racial Disparities in Cancer Care, and Prostate Cancer Disparities together to discuss relevant disparities-reducing topics and provide an opportunity for learning and networking.